Viking Holdings Ltd. VIK 深 沪
交易中 09-23 09:58:51 美东时间
62.95
+0.300
+0.48%
华盛通- 最 高63.195
- 今 开62.65
- 成交量 4.53万股
- 最 低 62.65
- 昨 收 62.65
- 总市值 278.87亿
- 52周最高 65.37
- 市盈率 静 178.38
- 换手率 0.01%
- 52周最低 31.79
- 委 比 -68.42%
- 总股本 4.43亿
- 历史最高 65.37
- 量 比 0.67
- 振 幅 0.87%
- 历史最低 25.71
- 每 手 1
- 风险率 2.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Celcuity To Present Phase 3 VIKTORIA-1 Breast Cancer Data In Late-Breaking Oral Session At ESMO 2025
Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the Phase 3
09-22 21:17
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Truist Securities Maintains Hold on Viking Holdings, Raises Price Target to $59
Truist Securities analyst Patrick Scholes maintains Viking Holdings (NYSE:VIK) with a Hold and raises the price target from $55 to $59.
09-19 21:34
Vikas EcoTech Completes Dispatch of AGM Notice
Vikas EcoTech Limited ( ($IN:VIKASECO) ) has issued an announcement. Vikas EcoT...
09-09 06:42
Barclays Maintains Equal-Weight on Viking Holdings, Raises Price Target to $61
Barclays analyst Brandt Montour maintains Viking Holdings (NYSE:VIK) with a Equal-Weight and raises the price target from $55 to $61.
08-28 22:31
Celcuity's NDA For Gedatolisib In HR+/HER2- Breast Cancer Accepted Into FDA's Real-Time Oncology Review Program
Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration ("FDA") agreed to accept its New Drug
08-28 04:14
美股大行评级 | 潜在涨幅166.67%！美银证券上调Rocket Pharmaceuticals目标价至10美元，评级升至"买入"
今日重点评级关注：美银证券：上调Rocket Pharmaceuticals评级至"买入"，目标价从4美元升至10美元；花旗：维持小鹏汽车"买入"评级，目标价从29美元升至29.4美元
08-21 19:00
Viking's Premium Valuation Backed By Strong Growth, Analyst Notes
Viking Holdings Ltd (NYSE: VIK) shares slipped despite strong Q2 results and positive analyst outlook. Pricing power and growth potential cited.
08-21 01:59
Norwegian Cruise Lines' president steps down, reaffirms FY25 outlook
Norwegian Cruise Line Holdings (NYSE:NCLH) announced on Wednesday that the cruise operator's president, David Herrera, has left the company effective August 20, and has been replaced on an interim bas...
08-20 21:42
电话会总结 ｜ Viking(VIK)2025财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**： - Viking Holdings (VIK) 在2025财年第二季度实现总营收18.5%的同比增长，达到19亿美元。 - 调整后毛利（Adjusted Gross Margin）同比增长19.2%，达到12亿美元。 - 净利润（Net Income）为4.39亿美元，同比增加近2.8亿美元。 - 调整后EBITDA同比增长28.5%，达到6.33亿美元。 - 调整后每股收益（Adjusted EPS）为0.99美元。 - 截至2025年6月30日，递延收入（Deferr
08-20 12:05
